Advertisement
Skip to Content

iShares Biotechnology ETF IBB

Quantitative rating as of | See iShares Investment Hub

Morningstar’s Analysis IBB

Will IBB outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

iShares Biotechnology ETF earns a Morningstar Quantitative Rating of Negative with strength in areas such as People offset by weaker spots such as Process. The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Unlock our full analysis with Morningstar Investor